Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Circulating Tumor Cells in Blood Can Predict a Patient’s Response to Chemotherapy

December 3, 2013 11:36 am | by University of Granada | News | Comments

Scientists from Granada have demonstrated, for the first time, that detecting circulating tumor cells (CTCs) in blood and studying the presence of certain genetic markers in them is a technique that allows specialists to predict, with great precision...

TOPICS:

Abbott Issues Voluntary Recall of Blood Glucose Test Strips

December 3, 2013 11:31 am | by FDA | News | Comments

Abbott has announced it is initiating a voluntary recall of 20 lots of FreeStyle and FreeStyle Lite Blood Glucose Test Strips in the United States. These lots of test strips may produce erroneously low blood glucose results when used with both...

TOPICS:

Predict Alzheimer's Disease Within Two Years of Screening

December 3, 2013 11:24 am | by Université de Montréal | News | Comments

In their study, Sylvie Belleville and her team accurately predicted (at a rate of 90%) which of their research subjects with mild cognitive impairment would receive a clinical diagnosis of Alzheimer's disease within the following two years and...

TOPICS:
Advertisement

Amazing Robotic Hand Made with 3D Printer

December 3, 2013 11:19 am | by SWNS TV | Videos | Comments

An inventor has unveiled his plans to revolutionize the health industry by creating prosthetic limbs using a 3D printer. The NHS currently has to pay around £70,000 for a prosthetic hand for an amputee. But robotics expert Joel Gibbard, 23...

TOPICS:

Trice Orthopedics lands $3M bridge loan

December 3, 2013 11:18 am | by Mass Device | News | Comments

Trice Orthopedics said it closed a bridge loan financing worth about $3 million. The King Of Prussia, Pa.-based medical device company said BioStar Ventures led the round, along with Millennium Life Sciences, existing investors and several new...

TOPICS:

Researchers Turn to Machines to Identify Breast Cancer Type

December 3, 2013 11:06 am | by University of Alberta | News | Comments

Researchers from the University of Alberta and Alberta Health Services have created a computer algorithm that successfully predicts whether estrogen is sending signals to cancer cells to grow into tumors in the breast. By finding this hormone...

TOPICS:

Photo of the Day: Printing the Human Body

December 3, 2013 11:00 am | by PrinterInks | News | Comments

Using modified printer cartridges and extracted cells as the basis, scientists have a discovered a way in which to print human tissue. While this amazing concept is still at an early stage, the future of bioprinting (as it’s commonly known) will...

TOPICS:

Volcano launches $200M stock buyback

December 3, 2013 10:26 am | by Mass Device | News | Comments

A stock buyback worth up to $200 million sent shares of Volcano up nearly 6% this morning. Volcano said yesterday after the market's close that its board authorized the share repurchasing program, including an accelerated plan worth $100 million...

Advertisement

Cambridge Heart chairman, ex-CEO both resign | Personnel Moves

December 3, 2013 10:00 am | by Mass Device | News | Comments

Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company. De Greef, chairman since 2008, was the Cambridge Heart's...

GE Healthcare’s “Brilliant Machines” Software Innovations Transforms the Patient Experience by Reducing Wait Times and Helping Hospital Staff Increase Efficiency

December 3, 2013 10:00 am | by Business Wire | News | Comments

Today at the 2013 Radiological Society of North America (RSNA) annual meeting, GE Healthcare, a unit of General Electric Company (NYSE: GE), unveiled four software breakthroughs to deliver improved clinical capabilities, productivity and diagnostic...

TOPICS:

Xlumena wraps up $25M Series C round

December 3, 2013 9:41 am | by Mass Device | News | Comments

Xlumena said it closed a $25 million Series C round it plans to use to expand its commercial footprint and win FDA clearance for its Axios stent and delivery system. Mountain View, Calif.-based Xlumena said the round was led by Third Point...

TOPICS:

Definiens Releases 2013 Survey Results: Top 4 Adoption Drivers for Image Analysis in Digital Pathology

December 3, 2013 9:30 am | by Business Wire | News | Comments

Definiens, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, today released results from an industry survey on the drivers of automated image analysis adoption and predictions...

TOPICS:

Interrad Medical Awarded HealthTrust Contract for Its SecurAcath Catheter Securement Device

December 3, 2013 9:00 am | by Business Wire | News | Comments

HealthTrust, a healthcare group purchasing and total cost management solutions company has awarded Interrad Medical a contract for its SecurAcath catheter securement device. Effective November 12, 2013, the agreement makes the SecurAcath...

TOPICS:

St. Jude Medical Launches US Study of New Prodigy Neurostimulator to Evaluate Burst Stimulation Technology for Chronic Pain

December 3, 2013 8:00 am | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, has initiated a clinical study of the Prodigy ™ neurostimulator, the first spinal cord stimulation (SCS) system able to deliver a proprietary mode of stimulation therapy called burst...

TOPICS:

Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease

December 3, 2013 8:00 am | by Business Wire | News | Comments

Cardiovascular Systems, Inc. has announced that its new Diamondback 360 Coronary Orbital Atherectomy System (OAS) is being used by physicians across the country to treat coronary artery disease. This follows the company’s recent PMA approval...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading